- Home
- LSF vs DTIL Comparison
LSF vs DTIL Comparison
Compare LSF & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSF
- DTIL
- Stock Information
- Founded
- LSF 2015
- DTIL 2006
- Country
- LSF United States
- DTIL United States
- Employees
- LSF N/A
- DTIL N/A
- Industry
- LSF Packaged Foods
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- LSF Consumer Staples
- DTIL Health Care
- Exchange
- LSF Nasdaq
- DTIL Nasdaq
- Market Cap
- LSF 61.6M
- DTIL 55.3M
- IPO Year
- LSF 2020
- DTIL 2019
- Fundamental
- Price
- LSF $5.64
- DTIL $4.66
- Analyst Decision
- LSF Strong Buy
- DTIL Strong Buy
- Analyst Count
- LSF 2
- DTIL 2
- Target Price
- LSF $12.00
- DTIL $47.00
- AVG Volume (30 Days)
- LSF 33.5K
- DTIL 75.4K
- Earning Date
- LSF 11-05-2025
- DTIL 11-03-2025
- Dividend Yield
- LSF N/A
- DTIL N/A
- EPS Growth
- LSF N/A
- DTIL N/A
- EPS
- LSF N/A
- DTIL N/A
- Revenue
- LSF $47,027,546.00
- DTIL $1,261,000.00
- Revenue This Year
- LSF $21.88
- DTIL N/A
- Revenue Next Year
- LSF $20.86
- DTIL $135.19
- P/E Ratio
- LSF N/A
- DTIL N/A
- Revenue Growth
- LSF 22.79
- DTIL N/A
- 52 Week Low
- LSF $3.60
- DTIL $3.61
- 52 Week High
- LSF $10.90
- DTIL $10.64
- Technical
- Relative Strength Index (RSI)
- LSF 40.11
- DTIL 43.53
- Support Level
- LSF $5.68
- DTIL $4.86
- Resistance Level
- LSF $5.99
- DTIL $5.17
- Average True Range (ATR)
- LSF 0.23
- DTIL 0.23
- MACD
- LSF 0.03
- DTIL -0.06
- Stochastic Oscillator
- LSF 7.52
- DTIL 22.03
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.